Table 3.
Characteristic | OR | 95% CI |
---|---|---|
Sex | ||
Male | Ref | |
Female | 1.20 | 1.09-1.31 |
Diagnosis | ||
Lymphoma | Ref | |
Myeloma | 1.36 | 1.22-1.52 |
Leukemia | 1.08 | 0.94-1.24 |
Myelodysplastic syndromes | 0.89 | 0.75-1.04 |
Age (y) | ||
67-69 | Ref | |
70-74 | 1.06 | 0.90-1.25 |
75-79 | 1.02 | 0.87-1.20 |
≥80 | 1.10 | 0.94-1.28 |
Marital status | ||
Married | Ref | |
Not married | 1.21 | 1.10-1.33 |
Race | ||
White | Ref | |
Non-White | 0.80 | 0.69-0.93 |
Education (census tract quintile) * | ||
1 (lowest) | Ref | |
2 | 0.87 | 0.76-1.00 |
3 | 0.88 | 0.76-1.01 |
4 | 0.89 | 0.77-1.04 |
5 (highest) | 0.84 | 0.71-0.98 |
Median income (census tract quintile)† | ||
1 (lowest) | Ref | |
2 | 1.00 | 0.87-1.15 |
3 | 0.92 | 0.79-1.06 |
4 | 0.98 | 0.84-1.13 |
5 (highest) | 0.94 | 0.81-1.09 |
Surveillance, Epidemiology, and End Results registry region | ||
Midwest | Ref | |
Northeast | 0.64 | 0.55-0.75 |
South | 0.76 | 0.66-0.88 |
West | 0.79 | 0.69-0.90 |
Charlson comorbidity score | ||
0 | Ref | |
1 | 1.21 | 1.09-1.35 |
2+ | 1.54 | 1.39-1.71 |
Precancer anxiety | ||
Absent | Ref | |
Present | 2.98 | 2.61-3.41 |
See Table 1 footnotes.